KHN’s ‘What the Health?’: Health Spending? Only Congress Knows

Top negotiators in Congress have agreed to a framework for government spending into next year, but there are details to iron out before a vote — such as the scheduled Medicare payment cuts that have providers worried. Also, the Biden administration reopens its program allowing Americans to request free covid-19 home tests, as hopes for pandemic preparedness measures from Congress dim. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Rebecca Adams of KHN join KHN’s Mary Agnes Carey to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Much of the CDC Is Working Remotely. That Could Make Changing the Agency Difficult.

Like many U.S. workplaces, the Centers for Disease Control and Prevention went remote during the pandemic. Most of the agency’s staff members haven’t returned to the office full time, raising concerns about the CDC’s ability to reform itself after recent stumbles.

Un nuevo uso de las aplicaciones de citas: perseguir infecciones sexuales

Con un surgimiento de las infecciones de transmisión sexual, trabajadores de salud pública encuentran en los apps de citas un espacio ideal para mensajes de prevención y rastreo de contactos.

Schools, Sheriffs, and Syringes: State Plans Vary for Spending $26B in Opioid Settlement Funds

The cash represents an unprecedented opportunity to derail the opioid epidemic, but with countless groups advocating for their share of the pie, the impact could depend heavily on geography and politics.

Mistrust and Polarization Steer Rural Governments to Reject Federal Public Health Funding

As the covid-19 pandemic grinds on, Elko County, Nevada, still lacks a public health department. Yet its elected leaders rejected federal funds that could have helped it create one. Decisions like the one in Elko, and ones made by officials with other state and local governments, leave health experts concerned about whether the country’s public health infrastructure will be prepared to handle future health challenges.

As STDs Proliferate, Companies Rush to Market At-Home Test Kits. But Are They Reliable?

The popularity of at-home covid tests has amplified calls from public health researchers and diagnostic companies to make home testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.

Pacientes se quejan de que algunas startups de atención de la obesidad ofrecen píldoras… y no mucho más

Muchos estadounidenses han recurrido a la última gran idea para perder peso; ya sean dietas de moda, la obsesión por el fitness, hierbas y píldoras poco fiables o la cirugía bariátrica. Parece que nunca acaban siendo la solución mágica con la que la gente sueña.

Sick Profit: Investigating Private Equity’s Stealthy Takeover of Health Care Across Cities and Specialties

Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.

Thousands of Experts Hired to Aid Public Health Departments Are Losing Their Jobs

As the covid-19 pandemic raged, an independent nonprofit tied to the Centers for Disease Control and Prevention hired an army of seasoned professionals to fill the gaps in the country’s public health system. Now, the money has largely run out, and state and local health departments are again without their expertise.

KHN’s ‘What the Health?’: The Midterm Shake-Up

Election night went better than expected for Democrats. Although they could still lose control of one or both houses of Congress, the predicted “red wave” for Republicans failed to materialize. Meanwhile, voters in both red and blue states approved ballot measures to protect abortion rights. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews Carolee Lee, the former jewelry magnate, about her efforts to boost gender equity in medical research.